Results of ambulatory pH monitoring do not reliably predict response to therapy in patients with eosinophilic oesophagitis.

Francis, D L; Foxx-Orenstein, A; Arora, A S; Smyrk, T C; Jensen, K; Nord, S L; Alexander, J A; Romero, Y; Katzka, D A

Francis, D L; Foxx-Orenstein, A; Arora, A S; Smyrk, T C; Jensen, K; Nord, S L; Alexander, J A; Romero, Y; Katzka, D A.

Affiliation

Francis DL; Division of Gastroenterology and Hepatology, Mayo Clinic Rochester, MN, USA. francis.dawn@mayo.edu

Aliment Pharmacol Ther ; 35(2): 300-7, 2012 Jan.

Article in En | MEDLINE | ID: mdl-22111863

Subject(s)

Anti-Inflammatory Agents/administration & dosage; Anti-Ulcer Agents/administration & dosage; Budesonide/administration & dosage; Eosinophilic Esophagitis/drug therapy; Esomeprazole/administration & dosage; Adult; Aged; Eosinophilic Esophagitis/physiopathology; Female; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Monitoring, Ambulatory; Predictive Value of Tests; Prospective Studies; Severity of Illness Index; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Budesonide / Eosinophilic Esophagitis / Esomeprazole / Anti-Inflammatory Agents / Anti-Ulcer Agents Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2012 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google